Evolus
EOLS
#7305
Rank
ยฃ0.34 B
Marketcap
ยฃ5.29
Share price
2.92%
Change (1 day)
-44.62%
Change (1 year)

Revenue for Evolus (EOLS)

Revenue in 2025 (TTM): ยฃ0.21 Billion

According to Evolus 's latest financial reports the company's current revenue (TTM ) is ยฃ0.21 Billion. In 2024 the company made a revenue of ยฃ0.21 Billion an increase over the revenue in the year 2023 that were of ยฃ0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Evolus from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.21 B2.64%
2024 ยฃ0.21 B33.77%
2023 ยฃ0.15 B29.13%
2022 ยฃ0.12 B66.36%
2021 ยฃ73.84 M78.02%
2020 ยฃ41.48 M55.74%
2019 ยฃ26.63 M
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA